- Home
- CBT vs HLN Comparison
CBT vs HLN Comparison
Compare CBT & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBT
- HLN
- Stock Information
- Founded
- CBT 2019
- HLN 2022
- Country
- CBT United States
- HLN United Kingdom
- Employees
- CBT N/A
- HLN N/A
- Industry
- CBT Major Chemicals
- HLN Package Goods/Cosmetics
- Sector
- CBT Industrials
- HLN Consumer Discretionary
- Exchange
- CBT Nasdaq
- HLN Nasdaq
- Market Cap
- CBT 4.3B
- HLN 45.6B
- IPO Year
- CBT N/A
- HLN N/A
- Fundamental
- Price
- CBT $73.90
- HLN $10.74
- Analyst Decision
- CBT Hold
- HLN Buy
- Analyst Count
- CBT 3
- HLN 1
- Target Price
- CBT $92.67
- HLN $10.95
- AVG Volume (30 Days)
- CBT 488.5K
- HLN 15.0M
- Earning Date
- CBT 05-05-2025
- HLN 02-27-2025
- Dividend Yield
- CBT 2.44%
- HLN 1.56%
- EPS Growth
- CBT N/A
- HLN 38.94
- EPS
- CBT 7.72
- HLN 0.20
- Revenue
- CBT $3,908,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- CBT $3.20
- HLN $4.78
- Revenue Next Year
- CBT $3.44
- HLN $4.75
- P/E Ratio
- CBT $9.56
- HLN $27.01
- Revenue Growth
- CBT N/A
- HLN N/A
- 52 Week Low
- CBT $71.64
- HLN $8.12
- 52 Week High
- CBT $117.46
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- CBT 37.23
- HLN 60.96
- Support Level
- CBT $71.64
- HLN $10.57
- Resistance Level
- CBT $78.85
- HLN $10.85
- Average True Range (ATR)
- CBT 2.12
- HLN 0.14
- MACD
- CBT -0.35
- HLN 0.05
- Stochastic Oscillator
- CBT 21.50
- HLN 87.21
About CBT Cabot Corporation
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.